細胞性癌 的英文怎麼說

中文拼音 [xìbāoxìngái]
細胞性癌 英文
cellular cancer
  • 細 : 形容詞1 （條狀物橫剖面小） thin; slender 2 （顆粒小） in small particles; fine 3 （音量小） thin ...
  • 胞 : Ⅰ名詞1 （胞衣） afterbirth2 （同一個國家或民族的人） fellow countryman; compatriot Ⅱ形容詞（同胞...
  • 性 : Ⅰ名詞1 （性格） nature; character; disposition 2 （性能; 性質） property; quality 3 （性別） sex ...
  • 癌 : 名詞[醫學] （惡性腫瘤） cancer; carcinoma
  • 細胞 : cell; sytes; bioplast; cella; [口語] gene; [生物學] cellule; cellule cellulli cellulo ; cello ; k...
  1. Alphafetoprotein production is only seen in liver cell carcinoma.

    甲胎蛋白的產生只見于肝細胞性肝癌。
  2. Neutrophilic granulocytopenia caused by chemotherapy of cancers including malignant lymphoma, small - cell carcinoma of the lung, embryonic cell tumor ( spermary tumor, ovary tumor ect. ), neuroblastoma and so on

    癌癥化療引起的中性粒細胞減少。包括惡性淋巴瘤、小細胞肺癌、胚胎細胞瘤（睪丸腫瘤、卵巢腫瘤等） 、神經母細胞瘤等。
  3. Nci - h1155, a human non - small - cell lung cancer line, was employed in a paclitaxel - dependent synthetic lethal screen designed to identify gene targets that specifically reduce cell iability in the presence of otherwise sublethal concentrations of paclitaxel

    Nci - h1155作為一種人類非小細胞肺癌的種株，可運用其在依賴紫杉醇殺傷性藥物合成過程中設計鑒別出靶基因，從而特異性減少未達到殺傷性致死量的紫杉醇藥物作用后腫瘤細胞仍存活的數量。
  4. Conclusions the addition of bevacizumab to paclitaxel plus carboplatin in the treatment of selected patients with non ? small - cell lung cancer has a significant survival benefit with the risk of increased treatment - related deaths. ( clinicaltrials. gov number, nct00021060 [ clinicaltrials. gov ]

    結論：紫杉醇-卡鉑加上貝伐單抗治療非小細胞肺癌，可明顯延長生存期，但治療相關性死亡風險也同時升高。
  5. Effect of shenfu injection on hematological toxic reactions induced by vinoreibine plus cisplatin in the treatment of non - small cell lung cancer

    參附註射液對長春瑞賓聯合順鉑方案治療非小細胞肺癌引起血液學毒性反應的影響
  6. Conclusion : for hcc patients with hb chronic infection / exposure, a high iral load prior to treatment is an aderse factor for surial and may be associated with a higher incidence of seere hepatitis during chemotherapy

    結論:有慢性乙肝感染或接觸史的肝細胞性肝癌患者，化療之前有高病毒負荷量是其生存的負面因素，並與化療期間急性肝炎的高發生率相關
  7. But it is extensively expressed on the majority of colorectal, gastric, and pancreatic carcinomas, and non - small cell lung cancers in the adult. so, cea can be used to the target of the tumors " detection and treatment in the adult

    成年後， cea的表達消失，但在胃腸道惡性腫瘤、胰腺癌、非小細胞肺癌和乳腺癌等癌細胞表面又可重新表達cea ，所以在成年人體內， cea可作為腫瘤檢測和治療的靶分子。
  8. Clear cell adenocarcinomas, although common in women, are very rare in the urinary tract of men, and occur predominantly in the urethra or urinary bladder

    透明細胞腺癌，盡管女性常見，但是發生在男性的泌尿道比較罕見，並且主要發生在尿道或者膀胱。
  9. Results sixteen genes that correlated with survival among patients with nsclc were identified by analyzing microarray data and risk scores

    結果：通過對微點陣數據和風險評分的分析， 16個與非小細胞肺癌患者的存活率有相關性的基因被鑒別出來。
  10. Combined chemotherapy of paclitaxel and cisplatin in the treatment of relapsed small cell lung cancer

    紫杉醇聯合順鉑治療復發性小細胞肺癌
  11. Hcc is a common cause of morbidity and mortality. for patients who are not candidates for curatie surgery, systemic chemotherapy is one of the standard treatments

    肝細胞性肝癌是發病和死亡的常見原因.對于不能手術切除腫瘤的患者，予全身化療是標準治療方案之一
  12. Future strategies to improe the prognosis of hcc patients undergoing chemotherapy should consider supportie therapy that incorporates antiiral therapies to reduce hb iral load

    將來要改善肝細胞性肝癌化療患者預后的措施應考慮同時給予減少病毒負荷量的抗病毒輔助治療
  13. Expression of apoptopsis regulatory proteins in primary resected non - small - cell lung cancer

    凋亡調節蛋白在手術切除的原發性非小細胞肺癌中的表達
  14. We report a 64 - year - old man previously diagnosed with limited stage small cell lung cancer that presented with painless hematuria and arf after a 2 - year relapse - free period

    我們報告一位六十四歲先前診斷為局限階段小細胞肺癌的男性病人，經過兩年無復發時期后，呈現出無痛性血尿和急性腎衰竭。
  15. Clinical evaluation of topotecan in treatment of patients with hard - cured small cell lung cancer

    拓撲替康單藥治療難治性小細胞肺癌的臨床評價
  16. Lung cancer is a common malignant tumor. its therapy draws more and more attention. main therapeutic regimens, including chemotherapy, radiotherapy and surgery, were summarized in this overview

    摘要肺癌系常見的惡性腫瘤，肺癌的治療受到廣泛關注，作者就目前小細胞性肺癌主要的治療方法（化學治療、放射治療、手術治療）進行扼要的綜述。
  17. The purpose of this study was to evaluate the prevalence of kit expression in patients with sclc and its prognostic value

    這項研究的目的是評估在小細胞肺癌患者中kit表達的普遍性和它的預后價值。
  18. Kit protein is expressed in sclc, and its kinase activity has been implicated in the pathophysiology of many tumours, including sclc

    Kit蛋白在小細胞肺癌中表達，它的激酶活性與許多腫瘤的病理生理學都有聯系，包括小細胞肺癌。
  19. The study, carried out in 286 patients with extensive sclc who had responded to systemic chemotherapy, compared prophylactic cranial irradiation with no further therapy

    這項研究納入286例對全身化療有反應的廣泛轉移小細胞肺癌患者，來比較預防性全腦放療和無其他進一步治療的結果。
  20. Background : small cell lung cancer ( sclc ) is a very aggressive disease, with poor survival rates despite standard treatment with combination chemotherapy with or without radiotherapy

    背景：小細胞肺癌（ sclc ）是一種非常有侵襲性的疾病，雖然通過標準治療加上聯合化療再加上或不加放射治療，存活率不高。
分享友人
分享到 Line

分享到臉書